ANTX
AN2 Therapeutics (ANTX)
$12
About AN2 Therapeutics (ANTX)
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.
Details
Daily high
$1.17
Daily low
$1.10
Price at open
$1.12
52 Week High
$1.55
52 Week Low
$1.01
Market cap
30.7M
Dividend yield
0.00%
Volume
22,969
Avg. volume
62,331
P/E ratio
-.99
AN2 Therapeutics News
Details
Daily high
$1.17
Daily low
$1.10
Price at open
$1.12
52 Week High
$1.55
52 Week Low
$1.01
Market cap
30.7M
Dividend yield
0.00%
Volume
22,969
Avg. volume
62,331
P/E ratio
-.99